Skip to content
OpenCapital
Get started

Kiniksa Pharmaceuticals International, plc KNSA Operating Lease ROU Assets

Operating Lease ROU Assets at other companies

Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
$6.83M-0.5%
Apogee Therapeutics, Inc. logo
Apogee Therapeutics, Inc.APGE
$7.71M-33.0%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$17.23M+140%
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$235.06M+47.6%
LQD
Liquidia CorporationLQDA
$4.36M+5.5%
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
$1.86M-13.9%

Other financials

Income statement

See full
Revenue$214.3M+55.5%
Gross profit$193.5M+61.3%
Operating income$29.3M+121%
Net income$22.6M+165%
EPS (diluted)$0.27+145%

Balance sheet

See full
Cash & equivalents$190.0M+20.9%
Total debt$9.0M-9.0%
Total equity$605.7M+32.4%
Total assets$825.3M+37.7%

Cash flow

See full
Operating cash flow$50.2M+125%
CapEx$161.0K+62.6%
Free cash flow$50.0M+125%

Valuation

See full
Market cap$4.58B+128%

Profitability

See full
Gross margin89.3%+3.5pp
Operating margin12.4%+10.2pp
Net margin9.7%+7.6pp
FCF margin21.8%+12.2pp

Returns & leverage

See full
Return on equity13.7%+11.3pp
Debt / equity0×0.0×
Current ratio3.8×+0.1×

Where this comes from

Reported directly by Kiniksa Pharmaceuticals International, plc in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Kiniksa Pharmaceuticals International, plc’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kiniksa Pharmaceuticals International, plc's operating lease rou assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Kiniksa Pharmaceuticals International, plc's operating lease ROU assets?
Kiniksa Pharmaceuticals International, plc (KNSA) reported operating lease ROU assets of $9.33M in Q1 2026.
How has Kiniksa Pharmaceuticals International, plc's operating lease ROU assets changed year-over-year?
Kiniksa Pharmaceuticals International, plc's operating lease ROU assets decreased by 10.7% year-over-year, from $10.45M to $9.33M.
What is the long-term trend for Kiniksa Pharmaceuticals International, plc's operating lease ROU assets?
Over 5 years (2020 to 2025), Kiniksa Pharmaceuticals International, plc's operating lease ROU assets has grown at a 8.4% compound annual growth rate (CAGR), from $6.57M to $9.81M.
What does operating lease ROU assets mean?
Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.